Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-690,550 and Atorvastatin in Rheumatoid Arthritis
NCT01059864Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tofacitinib oral solution in rheumatoid arthritis (RA), sponsored by Pfizer. Started Feb 2010; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01059864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059864.